Challenges in clinical design of immunotherapy trials for malignant glioma.

Challenges in clinical design of immunotherapy trials for malignant glioma.

Item
http://www.wikidata.org/entity/Q37640613
Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastomaPilot study of intratumoral injection of recombinant heat shock protein 70 in the treatment of malignant brain tumors in childrenInterleukin-13 receptor alpha 2-targeted glioblastoma immunotherapy.Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme.Molecular alterations in glioblastoma: potential targets for immunotherapy.Regulatory T cells are not a strong predictor of survival for patients with glioblastoma.Recent developments on immunotherapy for brain cancer.Dendritic cell immunotherapy versus bevacizumab plus irinotecan in recurrent malignant glioma patients: a survival gain analysis.Impact of temozolomide on immune response during malignant glioma chemotherapyImmunotherapy in glioblastoma: emerging options in precision medicineChallenges in immunotherapy presented by the glioblastoma multiforme microenvironment.Glioblastoma-associated microglia and macrophages: targets for therapies to improve prognosis.TRP-ing up brain tumors.Assessment of genetic markers and glioblastoma stem-like cells in activation of dendritic cells.miRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1.
P2860

Challenges in clinical design of immunotherapy trials for malignant glioma.

Item
http://www.wikidata.org/entity/Q37640613
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Challenges in clinical design of immunotherapy trials for malignant glioma.
@en
Challenges in clinical design of immunotherapy trials for malignant glioma.
@nl
type
label
Challenges in clinical design of immunotherapy trials for malignant glioma.
@en
Challenges in clinical design of immunotherapy trials for malignant glioma.
@nl
prefLabel
Challenges in clinical design of immunotherapy trials for malignant glioma.
@en
Challenges in clinical design of immunotherapy trials for malignant glioma.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Challenges in clinical design of immunotherapy trials for malignant glioma.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932